Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase S60.001: lactoferrin

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2023
  1. Alhumam,M.N., Alhumam,N. and Kandeel,M. \<br\>The Antimicrobial Bifunctional Camel Lactoferrin: In Silico and Molecular Dynamic Perspective\<br\>Biomed Res Int (2023) 2023, 2322286. PubMed  Europe PubMed DOI  PMC  EPMC
  2. Dyrda-Terniuk,T. and Pomastowski,P. \<br\>The Multifaceted Roles of Bovine Lactoferrin: Molecular Structure, Isolation Methods, Analytical Characteristics, and Biological Properties\<br\>J Agric Food Chem (2023) 71, 20500-20531. PubMed  Europe PubMed DOI  PMC  EPMC
    3. 2020
  3. Campione,E., Cosio,T., Rosa,L., Lanna,C., Di Girolamo,S., Gaziano,R., Valenti,P. and Bianchi,L. \<br\>Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation\<br\>Int J Mol Sci (2020) 21, PubMed  Europe PubMed DOI  V
  4. Madadlou,A. \<br\>Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2\<br\>Eur J Pharmacol (2020) 885, 173499. PubMed  Europe PubMed DOI  PMC  EPMC
    5. 2019
  5. Soboleva,S.E., Sedykh,S.E., Alinovskaya,L.I., Buneva,V.N. and Nevinsky,G.A. \<br\>Cow milk lactoferrin possesses several catalytic activities\<br\>Biomolecules (2019) 9, PubMed  Europe PubMed DOI
    6. 2016
  6. Eipper,S., Steiner,R., Lesner,A., Sienczyk,M., Palesch,D., Halatsch,M.E., Zaczynska,E., Heim,C., Hartmann,M.D., Zimecki,M., Wirtz,C.R. and Burster,T. \<br\>Lactoferrin is an allosteric enhancer of the proteolytic activity of cathepsin G\<br\>PLoS ONE (2016) 11, e0151509. PubMed  Europe PubMed DOI  PMC  EPMC
  7. Giese,M., Turiello,N., Molenda,N., Palesch,D., Meid,A., Schroeder,R., Basilico,P., Benarafa,C., Halatsch,M.E., Zimecki,M., Westhoff,M.A., Wirtz,C.R. and Burster,T. \<br\>Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells\<br\>Oncotarget (2016) 7, 74602-74611. PubMed  Europe PubMed DOI
    8. 2012
  8. Plaut,A.G. and St Geme,J.W., III \<br\>Lactoferrin\<br\>[ISSN:978-0-12-407742-3] (2012) 3, 3635-3640. DOI
    9. 2011
  9. Piotukh,K., Geltinger,B., Heinrich,N., Gerth,F., Beyermann,M., Freund,C. and Schwarzer,D. \<br\>Directed evolution of sortase A mutants with altered substrate selectivity profiles\<br\>J Am Chem Soc (2011) 133, 17536-17539. PubMed  Europe PubMed DOI
    10. 2010
  10. Serruto,D., Spadafina,T., Ciucchi,L., Lewis,L.A., Ram,S., Tontini,M., Santini,L., Biolchi,A., Seib,K.L., Giuliani,M.M., Donnelly,J.J., Berti,F., Savino,S., Scarselli,M., Costantino,P., Kroll,J.S., O'Dwyer,C., Qiu,J., Plaut,A.G., Moxon,R., Rappuoli,R., Pizza,M. and Arico,B. \<br\>Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans\<br\>Proc Natl Acad Sci U S A (2010) 107, 3770-3775. PubMed  Europe PubMed DOI  PMC  EPMC
    11. 2009
  11. Baker,E.N. and Baker,H.M. \<br\>A structural framework for understanding the multifunctional character of lactoferrin\<br\>Biochimie (2009) 91, 3-10. PubMed  Europe PubMed DOI  S
    12. 2008
  12. Clarke,S.R. and Foster,S.J. \<br\>IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin\<br\>Infect Immun (2008) 76, 1518-1526. PubMed  Europe PubMed DOI  PMC  EPMC
  13. Jacobsen,L.C., Sorensen,O.E., Cowland,J.B., Borregaard,N. and Theilgaard-Monch,K. \<br\>The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils\<br\>J Leukoc Biol (2008) 83, 1155-1164. PubMed  Europe PubMed DOI
    14. 2005
  14. Thomassen,E.A., van Veen,H.A., van Berkel,P.H., Nuijens,J.H. and Abrahams,J.P. \<br\>The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin\<br\>Transgenic Res (2005) 14, 397-405. PubMed  Europe PubMed DOI  S
    15. 2004
  15. Massucci,M.T., Giansanti,F., Di Nino,G., Turacchio,M., Giardi,M.F., Botti,D., Ippoliti,R., De Giulio,B., Siciliano,R., Donnarumma,G., Valenti,P., Bocedi,A., Polticelli,F., Ascenzi,P. and Antonini,G. \<br\>Proteolytic activity of bovine lactoferrin\<br\>Biometals (2004) 17, 249-255. PubMed  Europe PubMed DOI
  16. Ochoa,T.J. and Clearly,T.G. \<br\>Lactoferrin disruption of bacterial type III secretion systems\<br\>Biometals (2004) 17, 257-260. PubMed  Europe PubMed DOI
  17. Valenti,P., Berlutti,F., Conte,M.P., Longhi,C. and Seganti,L. \<br\>Lactoferrin functions: current status and perspectives\<br\>J Clin Gastroenterol (2004) 38, S127-S129. PubMed  Europe PubMed
    18. 2003
  18. Hendrixson,D.R., Qiu,J., Shewry,S.C., Fink,D.L., Petty,S., Baker,E.N., Plaut,A.G. and St Geme,J.W., III \<br\>Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites\<br\>Mol Microbiol (2003) 47, 607-617. PubMed  Europe PubMed DOI
  19. [YEAR:20-6-2003]Ohashi,A., Murata,E., Yamamoto,K., Majima,E., Sano,E., Le,Q.T. and Katunuma,N. \<br\>New functions of lactoferrin and beta-casein in mammalian milk as cysteine protease inhibitors\<br\>Biochem Biophys Res Commun (20-6-2003) 306, 98-103. PubMed  Europe PubMed DOI
    20. 2002
  20. Jameson,G.B., Anderson,B.F., Breyer,W.A., Day,C.L., Tweedie,J.W. and Baker,E.N. \<br\>Structure of a domain-opened mutant (R121D) of the human lactoferrin N-lobe refined from a merohedrally twinned crystal form\<br\>Acta Crystallogr D Biol Crystallogr (2002) 58, 955-962. PubMed  Europe PubMed DOI  S
  21. [YEAR:3-12-2002]Peterson,N.A., Arcus,V.L., Anderson,B.F., Tweedie,J.W., Jameson,G.B. and Baker,E.N. \<br\>"Dilysine trigger" in transferrins probed by mutagenesis of lactoferrin: crystal structures of the R210G, R210E, and R210L mutants of human lactoferrin\<br\>Biochemistry (3-12-2002) 41, 14167-14175. PubMed  Europe PubMed DOI  S
    22. 2000
  22. [YEAR:6-6-2000]Peterson,N.A., Anderson,B.F., Jameson,G.B., Tweedie,J.W. and Baker,E.N. \<br\>Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins\<br\>Biochemistry (6-6-2000) 39, 6625-6633. PubMed  Europe PubMed DOI  S
  23. [YEAR:8-12-2000]Plaut,A.G., Qiu,J. and St Geme,J.W., III \<br\>Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae\<br\>Vaccine (8-12-2000) 19 Suppl 1, S148-S152. PubMed  Europe PubMed DOI
    24. 1999
  24. Sun,X.L., Baker,H.M., Shewry,S.C., Jameson,G.B. and Baker,E.N. \<br\>Structure of recombinant human lactoferrin expressed in Aspergillus awamori\<br\>Acta Crystallogr D Biol Crystallogr (1999) 55, 403-407. PubMed  Europe PubMed DOI  E  S
    25. 1998
  25. Baker,E.N., Anderson,B.F., Baker,H.M., MacGillivray,R.T., Moore,S.A., Peterson,N.A., Shewry,S.C. and Tweedie,J.W. \<br\>Three-dimensional structure of lactoferrin. Implications for function, including comparisons with transferrin\<br\>Adv Exp Med Biol (1998) 443, 1-14. PubMed  Europe PubMed  S
  26. [YEAR:1-11-1998]Jameson,G.B., Anderson,B.F., Norris,G.E., Thomas,D.H. and Baker,E.N. \<br\>Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change\<br\>Acta Crystallogr D Biol Crystallogr (1-11-1998) 54, 1319-1335. PubMed  Europe PubMed  S
    27. 1997
  27. Elrod,K.C., Moore,W.R., Abraham,W.M. and Tanaka,R.D. \<br\>Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep\<br\>Am J Respir Crit Care Med (1997) 156, 375-381. PubMed  Europe PubMed DOI
  28. [YEAR:28-11-1997]Moore,S.A., Anderson,B.F., Groom,C.R., Haridas,M. and Baker,E.N. \<br\>Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution\<br\>J Mol Biol (28-11-1997) 274, 222-236. PubMed  Europe PubMed DOI  S
  29. [YEAR:14-1-1997]Nicholson,H., Anderson,B.F., Bland,T., Shewry,S.C., Tweedie,J.W. and Baker,E.N. \<br\>Mutagenesis of the histidine ligand in human lactoferrin: iron binding properties and crystal structure of the histidine-253 - >methionine mutant\<br\>Biochemistry (14-1-1997) 36, 341-346. PubMed  Europe PubMed DOI  S
    30. 1996
  30. Faber,H.R., Baker,C.J., Day,C.L., Tweedie,J.W. and Baker,E.N. \<br\>Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutants\<br\>Biochemistry (1996) 35, 14473-14479. PubMed  Europe PubMed DOI  S
  31. Faber,H.R., Bland,T., Day,C.L., Norris,G.E., Tweedie,J.W. and Baker,E.N. \<br\>Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrin\<br\>J Mol Biol (1996) 256, 352-363. PubMed  Europe PubMed DOI  S
    32. 1994
  32. Smith,C.A., Anderson,B.F., Baker,H.M. and Baker,E.N. \<br\>Structure of copper- and oxalate-substituted human lactoferrin at 2.0 A resolution\<br\>Acta Crystallogr D Biol Crystallogr (1994) 50, 302-316. PubMed  Europe PubMed DOI  S
    33. 1993
  33. Day,C.L., Anderson,B.F., Tweedie,J.W. and Baker,E.N. \<br\>Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 A resolution\<br\>J Mol Biol (1993) 232, 1084-1100. PubMed  Europe PubMed DOI  S
    34. 1989
  34. [YEAR:20-10-1989]Anderson,B.F., Baker,H.M., Norris,G.E., Rice,D.W. and Baker,E.N. \<br\>Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution\<br\>J Mol Biol (20-10-1989) 209, 711-734. PubMed  Europe PubMed DOI  S
    35. 1987
  35. Anderson,B.F., Baker,H.M., Dodson,E.J., Norris,G.E., Rumball,S.V., Waters,J.M. and Baker,E.N. \<br\>Structure of human lactoferrin at 3.2-A resolution\<br\>Proc Natl Acad Sci U S A (1987) 84, 1769-1773. PubMed  Europe PubMed  PMC  EPMC  S

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2023 EBI
Terms of use